Injectable formulation development is a time-consuming and complex process. On the basis of years of research and development (R&D) experience, the CD Formulation R&D team has established a complete, innovative Injectable Formulation Platform. This platform integrates various technologies and methods to support the development of a variety of complex injectables and long-acting injectables.
Injections usually include solutions, suspensions, emulsions, powder injections, etc., which can be injected through veins, muscles, subcutaneous, and other channels to promote the rapid and accurate entry of drugs into the body to achieve the purposes of treatment, prevention, diagnosis, etc.
With the advancement of science and the development of technology, more and more innovative technologies have been used in the development of injections.
As a technology-based supplier of innovative drug delivery systems, CD Formulation is committed to the development and engineering research of innovative injections.
Our highly qualified team of experts continuously innovates and improves the advanced injectable platform to provide customers with an efficient, safe, and reliable delivery solution. Our injectable formulation platform combines state-of-the-art technology and expertise to support the development of a variety of complex injectables and long-acting injectables, including but not limited to:
Importantly, our injectables platform involves not only formulation research of innovative drugs but also generic drug development. With the expertise of Q1/Q2 (Q3) pharmaceutical deformulation and reverse engineering, we can provide you with professional and rapid generic drug development services.
| Technology platform | Methods |
|---|---|
| Liposome technology | Our liposome technology involves encapsulating drugs within liposomes to improve their stability, solubility, and rate of release in the body. Commonly used liposome materials include phospholipids, cholesterol, PEG, etc. |
| Nanoparticle technology | Our nanoparticle technology involves combining drugs with nanoparticles through synthesis or modification methods to improve the solubility, bioavailability, and targeting properties of the drug. Commonly used nanoparticle materials include temperature-responsive nanocarriers, light-responsive nanocarriers, pH-responsive nanocarriers, redox-responsive nanocarriers, enzyme-responsive nanocarriers, etc. |
| Nanoemulsification technology | Our nanoemulsion technology involves the encapsulation of poorly water-soluble drugs in the oil phase of cholesterol-phospholipid-based nanoemulsions to enhance bioavailability while using minimal amounts of organic solvents and surfactants to enhance efficacy. |
| Nanosuspension emulsification technology | Our nanosuspension emulsion technology involves nano-processing low-solubility compounds so that they are dispersed in the aqueous phase to form a stable emulsion system to achieve long-term release. |
| Solubilization technology | Our solubilization technology mainly uses solid dispersion solubilization technology to improve solubility. |
In order to support the development of a variety of injectable formulations, our innovative injectable formulation platform is equipped with first-class equipment and testing instruments, including but not limited to:
CD Formulation has always been at the forefront of the development of innovative drug delivery systems. Thanks to our advanced Injectable formulation platform, we provide complex injectables and long-acting injectables development and production services to customers around the world. If you are interested in our services, please contact us today.
Easy access to products and services you need from our library via powerful searching tools.
